Arts

Books

Fashion & Beauty

Performing Arts

Food

Visual Arts

Design

Business

Entrepreneurship

Investing

Marketing

Careers

Management

Non-Profit

Comedy

Stand-Up

Comedy Interviews

Improv

Education

Self-Improvement

How To

Courses

Language Learning

Fiction

Comedy Fiction

Drama

Science Fiction

Government

Health & Fitness

Medicine

Alternative Health

Nutrition

Mental Health

Fitness

Sexuality

History

Kids & Family

Parenting

Stories for Kids

Education for Kids

Pets & Animals

Leisure

Video Games

Games

Automotive

Animation & Manga

Hobbies

Aviation

Home & Garden

Crafts

Music

Music Commentary

Music Interviews

Music History

News

Sports News

Entertainment News

News Commentary

Politics

Daily News

Business News

Tech News

Religion & Spirituality

Christianity

Spirituality

Religion

Judaism

Islam

Buddhism

Hinduism

Science

Social Sciences

Life Sciences

Natural Sciences

Nature

Chemistry

Mathematics

Earth Sciences

Physics

Astronomy

Society & Culture

Documentary

Relationships

Philosophy

Personal Journals

Places & Travel

Sports

Golf

Soccer

Wrestling

Basketball

Football

Fantasy Sports

Baseball

Wilderness

Running

Hockey

Rugby

Cricket

Volleyball

Tennis

Swimming

Technology

True Crime

TV & Film

Film Interviews

TV Reviews

After Shows

Film Reviews

Film History

Dans la cadre de l'année internationale de la Chimie 2011, nous vous proposons une série de conférences autour de thèmes d'actualité de la Chimie. Pour le grand public.

Les mardis de la Chimie

Türkiye'den çıkıp ülkemizde ve yurtdışında akademik çalışmalar yürüten bilim insanlarıyla yaptığımız yayınlardır.

Canlı Bilim: Bilimsel Sohbetler, Canlı Yayınlar...

Novidades da química e ciências, temas do cotidiano, bate-papo descontraído, conversas sobre experiências na vida acadêmica.

Química do dia a dia e divulgação científica, você encontra aqui!

Dúvides, sugestões e caneladas através do e-mail: oquimicast@gmail.com

Chave PIX para apoiar o projeto: quimicastpix@gmail.com

Novidades da química e ciências, temas do cotidiano, bate-papo descontraído, conversas sobre experiências na vida acadêmica. Química do dia a dia e divulgação científica, você encontra aqui! Dúvides, sugestões e caneladas através do e-mail: oquimicast@gmail.com Chave PIX para apoiar o projeto: quimicastpix@gmail.com

QuimiCast

Consigli, approfondimenti e peripezie di una farmacista digitale.

Pillole di Alice Pharmacist

Welcome to the EC Podcast!

In this new season, we will be discussing the latest developments, challenges and trends in the international coatings industry. 
We will be joined by international experts who will discuss these topics from within our sector.

A new episode will be released on the second Wednesday of every month, and additional content will be posted throughout the season! Follow and subscribe to the podcast to stay up to date! (It's free!)

Link to our main Website: https://www.european-coatings.com/

Welcome to the EC Podcast! In this new season, we will be discussing the latest developments, challenges and trends in the international coatings industry. We will be joined by international experts who will discuss these topics from within our sector. A new episode will be released on the second Wednesday of every month, and additional content will be posted throughout the season! Follow and subscribe to the podcast to stay up to date! (It's free!) Link to our main Website: https://www.european-coatings.com/

European Coatings Podcast

Informar a las personas sobre las Energías renovables

Las Energías renovables

O Adão Sem Paraíso foi criado com o intuito de conversar sobre temas pouco explorados e conhecidos . Sua principal pauta é a educação de ciência e seu papel social.

Adão Sem Paraíso

Vše o alchymii a chemii - lidech, místech a historii
All about alchemy and chemistry - people, places and history

Vše o alchymii a chemii - lidech, místech a historii All about alchemy and chemistry - people, places and history

Alchemy

Para os curiosos sobre a história da Química e assuntos que vão desde a área da medicina até às ciências socioeconômicas. Ficou interessado? Então, este podcast é pra você!!!

Química em Volume 🔊

Podcast ini adalah podcast official dari HMPS Pendidikan Kimia UIN Jakarta, yang dikelola oleh departemen Kominfo. Salam baik! #Kompod

KOMPOD!

Kendra Nicole

Bem vindos ao Podcast “Na Bancada” da Acore Consumíveis
A Acore é uma empresa que trabalha no segmento analítico, atendendo principalmente o mercado de colunas para cromatografia líquida e gasosa.
Neste Podcast, os especialistas de aplicações da Acore convidarão profissionais inseridos neste meio científico para bate-papos descontraídos sobre projetos, aplicações, técnicas de análise e dúvidas de usuários sobre o universo da química analítica!
É a Acore descomplicando a química!

Bem vindos ao Podcast “Na Bancada” da Acore Consumíveis A Acore é uma empresa que trabalha no segmento analítico, atendendo principalmente o mercado de colunas para cromatografia líquida e gasosa. Neste Podcast, os especialistas de aplicações da Acore convidarão profissionais inseridos neste meio científico para bate-papos descontraídos sobre projetos, aplicações, técnicas de análise e dúvidas de usuários sobre o universo da química analítica! É a Acore descomplicando a química!

Na Bancada

We live in a world of opinions. Listen to the thoughts and views of Zach Wiegand and Mark Petkov. As they discuss, argue and contemplate the philosophy of modern life. Audio Pong Patreon: https://www.patreon.com/user?u=54765200audiopong@gmail.com

We live in a world of opinions. Listen to the thoughts and views of Zach Wiegand and Mark Petkov. As they discuss, argue and contemplate the philosophy of modern life. Audio Pong Patreon: https://www.patreon.com/user?u=54765200 audiopong@gmail.com

Audio Pong

Lígia Bernardo

Siklus

CHemiCaL GuRuJi

TEMA DUREZA

Sobreviviendo a la COVID-19 en México, el remedio olvidado

This podcast is a general guideline for information and not a specific tutorial for any specific syllabus; therefore, it should not be relied upon. StudySquare Ltd and any people involved in producing this podcast take no responsibility or liability for any potential errors or omissions regarding this podcast and make no guarantees of any completeness, accuracy, or usefulness of the information contained in this podcast, its structure or its show notes.

A-level Chemistry Revision with Jonas

Welcome to the Calix Podcast Series INNOVATING FOR THE EARTH, with innovation expert and radio and TV presenter James O’Loghlin.

Calix Podcast INNOVATING FOR THE EARTH

MDMA (3,4-methylenedioxymethamphetamine), known commonly as Ecstasy or Molly, has transitioned from a popular recreational drug to a promising therapeutic tool. The unique psychoactive properties of MDMA, which enhance empathy and reduce fear, have made it a powerful aid in psychotherapy, particularly for treating severe psychological conditions like PTSD. This article delves into the historical context, mechanism of action, therapeutic applications, clinical trials, safety considerations, and future prospects of MDMA in therapeutic settings. MDMA has a fascinating history that spans over a century. It was first synthesized by the German pharmaceutical company Merck in 1912 as part of their research into blood-clotting medications. However, the psychoactive properties of MDMA remained unknown for decades. It wasn't until the 1970s that American chemist Alexander Shulgin re-synthesized MDMA in his lab. Shulgin, known for his pioneering work in psychedelic chemistry, recognized the unique effects of MDMA on the human psyche. Shulgin shared his findings with psychotherapist Leo Zeff, who saw the potential of MDMA as a therapeutic aid. Zeff introduced MDMA to the psychotherapy community, where it quickly gained popularity as a tool for facilitating emotional breakthroughs and enhancing the therapeutic alliance. Throughout the late 1970s and early 1980s, MDMA was used by a network of therapists who believed in its ability to catalyze healing. However, MDMA's rising popularity extended beyond therapeutic circles. It became a sought-after recreational drug, particularly in the rave and club scene. The increasing non-medical use of MDMA led to concerns about its potential for abuse and neurotoxicity. In 1985, the U.S. Drug Enforcement Administration (DEA) stepped in and classified MDMA as a Schedule I controlled substance. This classification placed severe restrictions on the legal use of MDMA, effectively halting its use in therapy and limiting research into its potential benefits. Despite the legal obstacles, a dedicated group of researchers and advocates continued to explore the therapeutic potential of MDMA. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) played a crucial role in advancing MDMA research, conducting clinical trials, and advocating for policy changes to facilitate its medical use. To understand how MDMA exerts its therapeutic effects, it's essential to examine its mechanism of action in the brain. MDMA primarily acts on three key neurotransmitter systems: serotonin, dopamine, and norepinephrine. When MDMA enters the brain, it causes a significant release of these neurotransmitters, leading to a cascade of psychological and physiological effects. Serotonin is perhaps the most important neurotransmitter involved in MDMA's action. MDMA causes a massive surge in serotonin levels, which is responsible for the drug's mood-elevating and prosocial effects. This increase in serotonin leads to feelings of euphoria, emotional warmth, and increased empathy. It allows individuals to connect with their emotions and with others in a profound way, which can be particularly beneficial in a therapeutic context. Dopamine, often associated with reward and motivation, is also affected by MDMA. The release of dopamine contributes to the pleasurable and energizing effects of the drug. It can enhance focus and engagement during therapy sessions, helping patients stay present and committed to the therapeutic process. Norepinephrine, a neurotransmitter involved in the body's stress response, is also increased by MDMA. This can lead to some of the physical effects of the drug, such as increased heart rate and blood pressure. However, the release of norepinephrine also plays a role in the emotional impact of MDMA. It can heighten emotional arousal and help individuals access and process difficult emotions. In addition to its effects on these neurotransmitters, MDMA has been shown to increase the release of oxytocin, often referred to as the "love hormone." Oxytocin is involved in social bonding, trust, and emotional regulation. The surge of oxytocin induced by MDMA can create a profound sense of connection and trust between the patient and therapist, fostering a strong therapeutic alliance. The combination of these neurochemical effects creates a unique psychological state characterized by reduced fear and defensiveness, increased empathy and emotional openness, and a heightened capacity for introspection and self-reflection. This state is particularly conducive to therapeutic work, allowing patients to access and process traumatic memories, emotions, and beliefs in a way that may not be possible under normal circumstances. It's important to note that the therapeutic effects of MDMA are not solely due to its pharmacological action. The drug is used as part of a carefully designed therapeutic protocol that includes preparatory sessions, MDMA-assisted sessions, and integrative follow-up sessions. The supportive and safe environment provided by trained therapists is crucial for maximizing the therapeutic potential of MDMA and minimizing the risks associated with its use. The therapeutic applications of MDMA are diverse and far-reaching, with the potential to address a range of mental health conditions. The most well-established and researched application of MDMA is in the treatment of post-traumatic stress disorder (PTSD). PTSD is a debilitating condition that can develop after exposure to a traumatic event, such as combat, sexual assault, or natural disasters. It is characterized by symptoms like intrusive memories, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and hyperarousal. Traditional treatments for PTSD, such as cognitive-behavioral therapy and medication, have limitations and are not effective for everyone. MDMA-assisted psychotherapy has emerged as a promising alternative for individuals with PTSD, particularly those who have not responded to conventional treatments. The unique properties of MDMA, such as reducing fear and increasing empathy, make it well-suited for treating the core symptoms of PTSD. During MDMA-assisted therapy sessions, patients are able to revisit and process traumatic memories in a safe and supportive environment. The drug reduces the fear and emotional numbing associated with these memories, allowing patients to engage with them in a more constructive way. They can access and express emotions that may have been suppressed or avoided, leading to a cathartic release and a new perspective on their experiences. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of research on MDMA-assisted therapy for PTSD. Their clinical trials have yielded impressive results, with a significant proportion of participants experiencing long-lasting improvements in their symptoms. In fact, the results have been so promising that the FDA has granted MDMA-assisted therapy a Breakthrough Therapy designation for PTSD, accelerating its path to approval. A recent article in The New York Times highlighted the anticipation surrounding the FDA's potential approval of MDMA-assisted therapy for PTSD. The article emphasized the transformative potential of this treatment, which could provide relief for the millions of individuals suffering from PTSD worldwide. It also underscored the importance of continued research and responsible use of MDMA in therapeutic settings. While PTSD is currently the primary focus of MDMA therapy research, there is growing interest in exploring its potential for other mental health conditions. Preliminary studies suggest that MDMA could be beneficial for treating depression, anxiety, and social anxiety in autistic adults. Depression, characterized by persistent low mood, loss of interest, and feelings of hopelessness, is a widespread and debilitating mental health condition. Current treatments, such as antidepressant medications and psychotherapy, are not always effective, leaving many individuals struggling with ongoing symptoms. MDMA's ability to promote emotional openness, self-compassion, and insight could make it a valuable tool in the treatment of depression. Similarly, MDMA's prosocial effects and reduction of fear could be particularly useful for individuals with anxiety disorders, including social anxiety disorder. By reducing the emotional barriers that prevent individuals from engaging in social situations, MDMA could facilitate exposure therapy and help individuals develop more adaptive coping strategies. Autism spectrum disorder (ASD) is another area where MDMA therapy shows promise. Many individuals with ASD struggle with social interactions and communication, which can lead to anxiety and isolation. MDMA's ability to enhance empathy and reduce social fears could help autistic adults navigate social situations more effectively and form meaningful connections with others. As research continues to expand, it's likely that new therapeutic applications of MDMA will emerge. The unique properties of this drug, combined with the supportive environment of psychotherapy, hold significant potential for addressing a range of mental health challenges. The resurgence of interest in MDMA as a therapeutic tool has been driven by a growing body of clinical research. In recent years, several landmark clinical trials have provided compelling evidence for the efficacy and safety of MDMA-assisted therapy, particularly for the treatment of PTSD. The most notable clinical trials have been conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization dedicated to the development of medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. MAPS has been at the forefront of MDMA research for over three decades, working tirelessly to advance the scientific understanding and clini

MDMA (3,4-methylenedioxymethamphetamine), known commonly as Ecstasy or Molly, has transitioned from a popular recreational drug to a promising therapeutic tool. The unique psychoactive properties of MDMA, which enhance empathy and reduce fear, have made it a powerful aid in psychotherapy, particularly for treating severe psychological conditions like PTSD. This article delves into the historical context, mechanism of action, therapeutic applications, clinical trials, safety considerations, and future prospects of MDMA in therapeutic settings. MDMA has a fascinating history that spans over a century. It was first synthesized by the German pharmaceutical company Merck in 1912 as part of their research into blood-clotting medications. However, the psychoactive properties of MDMA remained unknown for decades. It wasn't until the 1970s that American chemist Alexander Shulgin re-synthesized MDMA in his lab. Shulgin, known for his pioneering work in psychedelic chemistry, recognized the unique effects of MDMA on the human psyche. Shulgin shared his findings with psychotherapist Leo Zeff, who saw the potential of MDMA as a therapeutic aid. Zeff introduced MDMA to the psychotherapy community, where it quickly gained popularity as a tool for facilitating emotional breakthroughs and enhancing the therapeutic alliance. Throughout the late 1970s and early 1980s, MDMA was used by a network of therapists who believed in its ability to catalyze healing. However, MDMA's rising popularity extended beyond therapeutic circles. It became a sought-after recreational drug, particularly in the rave and club scene. The increasing non-medical use of MDMA led to concerns about its potential for abuse and neurotoxicity. In 1985, the U.S. Drug Enforcement Administration (DEA) stepped in and classified MDMA as a Schedule I controlled substance. This classification placed severe restrictions on the legal use of MDMA, effectively halting its use in therapy and limiting research into its potential benefits. Despite the legal obstacles, a dedicated group of researchers and advocates continued to explore the therapeutic potential of MDMA. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) played a crucial role in advancing MDMA research, conducting clinical trials, and advocating for policy changes to facilitate its medical use. To understand how MDMA exerts its therapeutic effects, it's essential to examine its mechanism of action in the brain. MDMA primarily acts on three key neurotransmitter systems: serotonin, dopamine, and norepinephrine. When MDMA enters the brain, it causes a significant release of these neurotransmitters, leading to a cascade of psychological and physiological effects. Serotonin is perhaps the most important neurotransmitter involved in MDMA's action. MDMA causes a massive surge in serotonin levels, which is responsible for the drug's mood-elevating and prosocial effects. This increase in serotonin leads to feelings of euphoria, emotional warmth, and increased empathy. It allows individuals to connect with their emotions and with others in a profound way, which can be particularly beneficial in a therapeutic context. Dopamine, often associated with reward and motivation, is also affected by MDMA. The release of dopamine contributes to the pleasurable and energizing effects of the drug. It can enhance focus and engagement during therapy sessions, helping patients stay present and committed to the therapeutic process. Norepinephrine, a neurotransmitter involved in the body's stress response, is also increased by MDMA. This can lead to some of the physical effects of the drug, such as increased heart rate and blood pressure. However, the release of norepinephrine also plays a role in the emotional impact of MDMA. It can heighten emotional arousal and help individuals access and process difficult emotions. In addition to its effects on these neurotransmitters, MDMA has been shown to increase the release of oxytocin, often referred to as the "love hormone." Oxytocin is involved in social bonding, trust, and emotional regulation. The surge of oxytocin induced by MDMA can create a profound sense of connection and trust between the patient and therapist, fostering a strong therapeutic alliance. The combination of these neurochemical effects creates a unique psychological state characterized by reduced fear and defensiveness, increased empathy and emotional openness, and a heightened capacity for introspection and self-reflection. This state is particularly conducive to therapeutic work, allowing patients to access and process traumatic memories, emotions, and beliefs in a way that may not be possible under normal circumstances. It's important to note that the therapeutic effects of MDMA are not solely due to its pharmacological action. The drug is used as part of a carefully designed therapeutic protocol that includes preparatory sessions, MDMA-assisted sessions, and integrative follow-up sessions. The supportive and safe environment provided by trained therapists is crucial for maximizing the therapeutic potential of MDMA and minimizing the risks associated with its use. The therapeutic applications of MDMA are diverse and far-reaching, with the potential to address a range of mental health conditions. The most well-established and researched application of MDMA is in the treatment of post-traumatic stress disorder (PTSD). PTSD is a debilitating condition that can develop after exposure to a traumatic event, such as combat, sexual assault, or natural disasters. It is characterized by symptoms like intrusive memories, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and hyperarousal. Traditional treatments for PTSD, such as cognitive-behavioral therapy and medication, have limitations and are not effective for everyone. MDMA-assisted psychotherapy has emerged as a promising alternative for individuals with PTSD, particularly those who have not responded to conventional treatments. The unique properties of MDMA, such as reducing fear and increasing empathy, make it well-suited for treating the core symptoms of PTSD. During MDMA-assisted therapy sessions, patients are able to revisit and process traumatic memories in a safe and supportive environment. The drug reduces the fear and emotional numbing associated with these memories, allowing patients to engage with them in a more constructive way. They can access and express emotions that may have been suppressed or avoided, leading to a cathartic release and a new perspective on their experiences. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of research on MDMA-assisted therapy for PTSD. Their clinical trials have yielded impressive results, with a significant proportion of participants experiencing long-lasting improvements in their symptoms. In fact, the results have been so promising that the FDA has granted MDMA-assisted therapy a Breakthrough Therapy designation for PTSD, accelerating its path to approval. A recent article in The New York Times highlighted the anticipation surrounding the FDA's potential approval of MDMA-assisted therapy for PTSD. The article emphasized the transformative potential of this treatment, which could provide relief for the millions of individuals suffering from PTSD worldwide. It also underscored the importance of continued research and responsible use of MDMA in therapeutic settings. While PTSD is currently the primary focus of MDMA therapy research, there is growing interest in exploring its potential for other mental health conditions. Preliminary studies suggest that MDMA could be beneficial for treating depression, anxiety, and social anxiety in autistic adults. Depression, characterized by persistent low mood, loss of interest, and feelings of hopelessness, is a widespread and debilitating mental health condition. Current treatments, such as antidepressant medications and psychotherapy, are not always effective, leaving many individuals struggling with ongoing symptoms. MDMA's ability to promote emotional openness, self-compassion, and insight could make it a valuable tool in the treatment of depression. Similarly, MDMA's prosocial effects and reduction of fear could be particularly useful for individuals with anxiety disorders, including social anxiety disorder. By reducing the emotional barriers that prevent individuals from engaging in social situations, MDMA could facilitate exposure therapy and help individuals develop more adaptive coping strategies. Autism spectrum disorder (ASD) is another area where MDMA therapy shows promise. Many individuals with ASD struggle with social interactions and communication, which can lead to anxiety and isolation. MDMA's ability to enhance empathy and reduce social fears could help autistic adults navigate social situations more effectively and form meaningful connections with others. As research continues to expand, it's likely that new therapeutic applications of MDMA will emerge. The unique properties of this drug, combined with the supportive environment of psychotherapy, hold significant potential for addressing a range of mental health challenges. The resurgence of interest in MDMA as a therapeutic tool has been driven by a growing body of clinical research. In recent years, several landmark clinical trials have provided compelling evidence for the efficacy and safety of MDMA-assisted therapy, particularly for the treatment of PTSD. The most notable clinical trials have been conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization dedicated to the development of medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. MAPS has been at the forefront of MDMA research for over three decades, working tirelessly to advance the scientific understanding and clini

MDMA (3,4-methylenedioxymethamphetamine), known commonly as Ecstasy or Molly, has transitioned from a popular recreational drug to a promising therapeutic tool. The unique psychoactive properties of MDMA, which enhance empathy and reduce fear, have made it a powerful aid in psychotherapy, particularly for treating severe psychological conditions like PTSD. This article delves into the historical context, mechanism of action, therapeutic applications, clinical trials, safety considerations, and future prospects of MDMA in therapeutic settings. MDMA has a fascinating history that spans over a century. It was first synthesized by the German pharmaceutical company Merck in 1912 as part of their research into blood-clotting medications. However, the psychoactive properties of MDMA remained unknown for decades. It wasn't until the 1970s that American chemist Alexander Shulgin re-synthesized MDMA in his lab. Shulgin, known for his pioneering work in psychedelic chemistry, recognized the unique effects of MDMA on the human psyche. Shulgin shared his findings with psychotherapist Leo Zeff, who saw the potential of MDMA as a therapeutic aid. Zeff introduced MDMA to the psychotherapy community, where it quickly gained popularity as a tool for facilitating emotional breakthroughs and enhancing the therapeutic alliance. Throughout the late 1970s and early 1980s, MDMA was used by a network of therapists who believed in its ability to catalyze healing. However, MDMA's rising popularity extended beyond therapeutic circles. It became a sought-after recreational drug, particularly in the rave and club scene. The increasing non-medical use of MDMA led to concerns about its potential for abuse and neurotoxicity. In 1985, the U.S. Drug Enforcement Administration (DEA) stepped in and classified MDMA as a Schedule I controlled substance. This classification placed severe restrictions on the legal use of MDMA, effectively halting its use in therapy and limiting research into its potential benefits. Despite the legal obstacles, a dedicated group of researchers and advocates continued to explore the therapeutic potential of MDMA. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) played a crucial role in advancing MDMA research, conducting clinical trials, and advocating for policy changes to facilitate its medical use. To understand how MDMA exerts its therapeutic effects, it's essential to examine its mechanism of action in the brain. MDMA primarily acts on three key neurotransmitter systems: serotonin, dopamine, and norepinephrine. When MDMA enters the brain, it causes a significant release of these neurotransmitters, leading to a cascade of psychological and physiological effects. Serotonin is perhaps the most important neurotransmitter involved in MDMA's action. MDMA causes a massive surge in serotonin levels, which is responsible for the drug's mood-elevating and prosocial effects. This increase in serotonin leads to feelings of euphoria, emotional warmth, and increased empathy. It allows individuals to connect with their emotions and with others in a profound way, which can be particularly beneficial in a therapeutic context. Dopamine, often associated with reward and motivation, is also affected by MDMA. The release of dopamine contributes to the pleasurable and energizing effects of the drug. It can enhance focus and engagement during therapy sessions, helping patients stay present and committed to the therapeutic process. Norepinephrine, a neurotransmitter involved in the body's stress response, is also increased by MDMA. This can lead to some of the physical effects of the drug, such as increased heart rate and blood pressure. However, the release of norepinephrine also plays a role in the emotional impact of MDMA. It can heighten emotional arousal and help individuals access and process difficult emotions. In addition to its effects on these neurotransmitters, MDMA has been shown to increase the release of oxytocin, often referred to as the "love hormone." Oxytocin is involved in social bonding, trust, and emotional regulation. The surge of oxytocin induced by MDMA can create a profound sense of connection and trust between the patient and therapist, fostering a strong therapeutic alliance. The combination of these neurochemical effects creates a unique psychological state characterized by reduced fear and defensiveness, increased empathy and emotional openness, and a heightened capacity for introspection and self-reflection. This state is particularly conducive to therapeutic work, allowing patients to access and process traumatic memories, emotions, and beliefs in a way that may not be possible under normal circumstances. It's important to note that the therapeutic effects of MDMA are not solely due to its pharmacological action. The drug is used as part of a carefully designed therapeutic protocol that includes preparatory sessions, MDMA-assisted sessions, and integrative follow-up sessions. The supportive and safe environment provided by trained therapists is crucial for maximizing the therapeutic potential of MDMA and minimizing the risks associated with its use. The therapeutic applications of MDMA are diverse and far-reaching, with the potential to address a range of mental health conditions. The most well-established and researched application of MDMA is in the treatment of post-traumatic stress disorder (PTSD). PTSD is a debilitating condition that can develop after exposure to a traumatic event, such as combat, sexual assault, or natural disasters. It is characterized by symptoms like intrusive memories, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and hyperarousal. Traditional treatments for PTSD, such as cognitive-behavioral therapy and medication, have limitations and are not effective for everyone. MDMA-assisted psychotherapy has emerged as a promising alternative for individuals with PTSD, particularly those who have not responded to conventional treatments. The unique properties of MDMA, such as reducing fear and increasing empathy, make it well-suited for treating the core symptoms of PTSD. During MDMA-assisted therapy sessions, patients are able to revisit and process traumatic memories in a safe and supportive environment. The drug reduces the fear and emotional numbing associated with these memories, allowing patients to engage with them in a more constructive way. They can access and express emotions that may have been suppressed or avoided, leading to a cathartic release and a new perspective on their experiences. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of research on MDMA-assisted therapy for PTSD. Their clinical trials have yielded impressive results, with a significant proportion of participants experiencing long-lasting improvements in their symptoms. In fact, the results have been so promising that the FDA has granted MDMA-assisted therapy a Breakthrough Therapy designation for PTSD, accelerating its path to approval. A recent article in The New York Times highlighted the anticipation surrounding the FDA's potential approval of MDMA-assisted therapy for PTSD. The article emphasized the transformative potential of this treatment, which could provide relief for the millions of individuals suffering from PTSD worldwide. It also underscored the importance of continued research and responsible use of MDMA in therapeutic settings. While PTSD is currently the primary focus of MDMA therapy research, there is growing interest in exploring its potential for other mental health conditions. Preliminary studies suggest that MDMA could be beneficial for treating depression, anxiety, and social anxiety in autistic adults. Depression, characterized by persistent low mood, loss of interest, and feelings of hopelessness, is a widespread and debilitating mental health condition. Current treatments, such as antidepressant medications and psychotherapy, are not always effective, leaving many individuals struggling with ongoing symptoms. MDMA's ability to promote emotional openness, self-compassion, and insight could make it a valuable tool in the treatment of depression. Similarly, MDMA's prosocial effects and reduction of fear could be particularly useful for individuals with anxiety disorders, including social anxiety disorder. By reducing the emotional barriers that prevent individuals from engaging in social situations, MDMA could facilitate exposure therapy and help individuals develop more adaptive coping strategies. Autism spectrum disorder (ASD) is another area where MDMA therapy shows promise. Many individuals with ASD struggle with social interactions and communication, which can lead to anxiety and isolation. MDMA's ability to enhance empathy and reduce social fears could help autistic adults navigate social situations more effectively and form meaningful connections with others. As research continues to expand, it's likely that new therapeutic applications of MDMA will emerge. The unique properties of this drug, combined with the supportive environment of psychotherapy, hold significant potential for addressing a range of mental health challenges. The resurgence of interest in MDMA as a therapeutic tool has been driven by a growing body of clinical research. In recent years, several landmark clinical trials have provided compelling evidence for the efficacy and safety of MDMA-assisted therapy, particularly for the treatment of PTSD. The most notable clinical trials have been conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization dedicated to the development of medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. MAPS has been at the forefront of MDMA research for over three decades, working tirelessly to advance the scientific understanding and clini

MDMA Therapy

Salute Magazine offre un ampio panorama sulla salute, dalla medicina alle ultime ricerche scientifiche, fino al wellness. Ogni episodio presenta interviste con esperti del settore, medici, ricercatori e professionisti, per esplorare temi legati al benessere fisico e mentale. Tra prevenzione, trattamenti innovativi, e nuovi sviluppi nel campo della medicina, il podcast ti aiuta a rimanere aggiornato sulle novità che possono migliorare la qualità della tua vita. Unisciti a noi per scoprire come le scelte quotidiane, le abitudini sane e i progressi scientifici possano fare la differenza nella tua salute.

Salute Magazine

Focusing exclusively on the technology within Gas Processing & LNG, 'Exploring Gas Processing & LNG Technologies' uncovers the innovative techniques and processes at the core of the industry. This podcast offers a deep dive into the technological advancements that enhance efficiency, safety, and sustainability in gas and LNG production. Through expert interviews, case study analysis, and technology spotlights, we bring you the cutting-edge insights that are shaping the future of energy. Join us on this journey to explore the innovations fueling a more efficient and sustainable energy landscape.

Focusing exclusively on the technology within Gas Processing &amp; LNG, 'Exploring Gas Processing &amp; LNG Technologies' uncovers the innovative techniques and processes at the core of the industry. This podcast offers a deep dive into the technological advancements that enhance efficiency, safety, and sustainability in gas and LNG production. Through expert interviews, case study analysis, and technology spotlights, we bring you the cutting-edge insights that are shaping the future of energy. Join us on this journey to explore the innovations fueling a more efficient and sustainable energy landscape.

Exploring Gas Processing & LNG Technologies

Kemiker Magnus og Biokemiker Morten rangerer alt kemi. Det er en kolossal opgave, men nogen må jo gøre det! I denne podcast snakker vi uformelt om kemi, men også om meget andet: mad, historie, samfund, kultur og tit rumraketter! Og det er netop fordi alt er kemi! Rangeringen bliver på en klassisk "tier" liste, hvor S er super bedst og F er værst. Vi håber i vil lytte med og hygge jer sammen med os. Find links til alle steder vi har vores podcast her: https://linktr.ee/yeolchemistrylab Derudover er der også links til vores SoMe der. Man kan, hvis man ønsker, støtte os her: https://10er.com/yeolchemistrylab

Kemiker Magnus og Biokemiker Morten rangerer alt kemi. Det er en kolossal opgave, men nogen må jo gøre det! I denne podcast snakker vi uformelt om kemi, men også om meget andet: mad, historie, samfund, kultur og tit rumraketter! Og det er netop fordi alt er kemi! Rangeringen bliver på en klassisk "tier" liste, hvor S er super bedst og F er værst. Vi håber i vil lytte med og hygge jer sammen med os. Find links til alle steder vi har vores podcast her: https://linktr.ee/yeolchemistrylab Derudover er der også links til vores SoMe der. Man kan, hvis man ønsker, støtte os her: https://10er.com/yeolchemistrylab

Ye Ol Chemistry Lab

Podcast educativo sobre Ciencias, matemática, química y física.

La tabla periódica y los elementos

Подкаст "Жизнь и судьба" это подкаст-встреча со старыми друзьями, коллегами, приятелями, и просто хорошими людьми. В подкасте мы обсуждаем, что произошло в нашей жизни с последней встречи, делимся интересными профессиональными и жизненными инсайтами, раскрываем разные профессии, виды деятельности и просто кайфуем от жизни! Живое общение залог выработки эндорфинов, чего и Вам желаем. Ссылка на телеграмм-канал автора: @intellectualla Ссылка на you-tube канал: https://www.youtube.com/@valentinaivashchenko

Подкаст "Жизнь и судьба" это подкаст-встреча со старыми друзьями, коллегами, приятелями, и просто хорошими людьми. В подкасте мы обсуждаем, что произошло в нашей жизни с последней встречи, делимся интересными профессиональными и жизненными инсайтами, раскрываем разные профессии, виды деятельности и просто кайфуем от жизни! Живое общение залог выработки эндорфинов, чего и Вам желаем. Ссылка на телеграмм-канал автора: @intellectualla Ссылка на you-tube канал: https://www.youtube.com/@valentinaivashchenko

Подкаст "Жизнь и судьба" это подкаст-встреча со старыми друзьями, коллегами, приятелями, и просто хорошими людьми. В подкасте мы обсуждаем, что произошло в нашей жизни с последней встречи, делимся интересными профессиональными и жизненными инсайтами, раскрываем разные профессии, виды деятельности и просто кайфуем от жизни! Живое общение залог выработки эндорфинов, чего и Вам желаем. Ссылка на телеграмм-канал автора: @intellectualla Ссылка на you-tube канал: https://www.youtube.com/@valentinaivashchenko

Жизнь и судьба

A special segment on Money FM 89.3's Breakfast Show that brings you on an exclusive audio journey to the ends of the world, covering in-depth environment, natural history and climate change stories that intertwine with human life on Earth.

A special segment on Money FM 89.3's Breakfast Show that brings you on an exclusive audio journey to the ends of the world, covering in-depth environment, natural history and climate change stories that intertwine with human life on Earth.

Climate Connections

Explicando as funções inorgânicas

for my alex

Prozessindustrie und Nachhaltigkeit sind keinesfalls Gegensätze, sondern zwei Seiten der gleichen Medaille. Sie ergänzen, ja sie bedingen sich vielfach. Was treibt die Verantwortlichen derzeit um? Im PROCESS-Podcast GreenTEC gehen wir dem auf den Grund und zeigen innovative, grüne Lösungen für eine nachhaltige Zukunft der Branche.

GreenTEC

Welcome to the Generating a Cleaner Future podcast, a brand-new audio series from Air Products exploring the challenges and opportunities for the hydrogen economy and the role of policy, technology and finance in maximising hydrogen’s potential.   
 
With the help of experts from across the hydrogen industry and beyond, the podcast looks at the key factors that will determine hydrogen’s scale-up and the crucial role it can play in decarbonising transport, engineering, and manufacturing. We also dive into the hard-to-abate industries that pose a bigger challenge to decarbonisation, and how we can overcome this to help the world deliver on its net zero promises.

Welcome to the Generating a Cleaner Future podcast, a brand-new audio series from Air Products exploring the challenges and opportunities for the hydrogen economy and the role of policy, technology and finance in maximising hydrogen’s potential. With the help of experts from across the hydrogen industry and beyond, the podcast looks at the key factors that will determine hydrogen’s scale-up and the crucial role it can play in decarbonising transport, engineering, and manufacturing. We also dive into the hard-to-abate industries that pose a bigger challenge to decarbonisation, and how we can overcome this to help the world deliver on its net zero promises.

Generating a Cleaner Future

Southeast Asia is highly interconnected, so it’s easy to move between countries by bus, train, or budget airlines. Some popular routes include Thailand to Cambodia and Vietnam to Laos.

Southeast Asia is highly interconnected, so it’s easy to move between countries by bus, train, or budget airlines. Some popular routes include Thailand to Cambodia and Vietnam to Laos.

Backpacking through Southeast Asia

On Lubrication Experts, Rafe Britton talk with the best in the business about all things lubricants, engineering and industry. From lubricant technology and condition monitoring to supply chain and manufacturing the experts sit down to give their take on the current and future states of the industry.

Lubrication Experts

Chemistry as a discipline has a reputation to the public of being boring, hard to understand, and dry. However, there are both people and experiments that changed history. We will cover laboratory and industrial accidents, cases of fraud like Jan Hendrik Schön, and the man that has caused more harm to earth’s atmosphere than any other single organism Thomas Midgley Jr. We will talk about the greatest chemists and their lives from Marie Curie to Rosalind Franklin to Neils Bohr to Glenn Seaborg. The Chemistry of everyday things like medications, tattoo ink, soaps and cleaners, cosmetics, sunscreen, and more! Join us for Cowboy Chemistry!

Cowboy Chemistry

Lecture-casts- A Podcast Lecture-Series on General Chemistry. Please note the views of this podcast represent those of my guest(s) and I.

Lecture-casts- A Podcast Lecture-Series on General Chemistry. Please note the views of this podcast represent those of my guest(s) and I.

"Lecture-casts"- A Lecture Series on General Chemistry

Each podcast contains timely nutritional information from Adisseo and industry experts.&nbsp; &nbsp; The conversational Transition Health series focuses on solutions to transition health concerns.&nbsp; &nbsp; The previous two series present research highlights from the 2021 and 2022 American Dairy Science Association (ADSA) Annual Meetings.&nbsp; &nbsp; The latest serie focuses on Amino Acid balancing for Lifetime Performance as we are celebrating the 30th anniversary of AA balancing in 2023.

Each podcast contains timely nutritional information from Adisseo and industry experts.    The conversational Transition Health series focuses on solutions to transition health concerns.    The previous two series present research highlights from the 2021 and 2022 American Dairy Science Association (ADSA) Annual Meetings.    The latest serie focuses on Amino Acid balancing for Lifetime Performance as we are celebrating the 30th anniversary of AA balancing in 2023.

Smart Science Series™ Ruminant Podcasts

En ConCiencia hablaremos de una manera amena sobre los productos de Polioles, aplicaciones, tendencias en el mercado y avances en la industria química; teniendo como invitados a diferentes expertos en el tema.Quédate y reta a tu mente para crear ConCiencia.Polioles es una empresa petroquímica dedicada a la fabricación y comercialización de productos químicos con una trayectoria de más de 55 años en el mercado. Síguenos en <a href="https://www.linkedin.com/company/poliolesmx/about/" rel="nofollow">LinkedIn</a> y si tienes dudas comunícate con nosotros.Para mayor información pueden ingresar a nuestra página web.<a href="http://polioles.com.mx" rel="nofollow">http://polioles.com.mx</a>Produced by <a href="ELLUCHADOR.AUDIO/SERVICES" rel="nofollow">El Luchador Audio</a>

En ConCiencia hablaremos de una manera amena sobre los productos de Polioles, aplicaciones, tendencias en el mercado y avances en la industria química; teniendo como invitados a diferentes expertos en el tema.Quédate y reta a tu mente para crear ConCiencia. Polioles es una empresa petroquímica dedicada a la fabricación y comercialización de productos químicos con una trayectoria de más de 55 años en el mercado. Síguenos en LinkedIn y si tienes dudas comunícate con nosotros. Para mayor información pueden ingresar a nuestra página web. http://polioles.com.mx Produced by El Luchador Audio

En ConCiencia hablaremos de una manera amena sobre los productos de Polioles, aplicaciones, tendencias en el mercado y avances en la industria química; teniendo como invitados a diferentes expertos en el tema.Quédate y reta a tu mente para crear ConCiencia.Polioles es una empresa petroquímica dedicada a la fabricación y comercialización de productos químicos con una trayectoria de más de 55 años en el mercado. Síguenos en <a href="https://www.linkedin.com/company/poliolesmx/about/" rel="noopener noreferrer">LinkedIn</a> y si tienes dudas comunícate con nosotros.Para mayor información pueden ingresar a nuestra página web.<a href="http://polioles.com.mx" rel="noopener noreferrer">http://polioles.com.mx</a>Produced by <a href="ELLUCHADOR.AUDIO/SERVICES" rel="noopener noreferrer">El Luchador Audio</a>

Polioles ConCiencia

Intensificación de procesos químicos y bioquímicos para la valorización de productos y servicios bajo un modelo sostenible de economía circular busca establecer alternativas para la intensificación de procesos químicos y bioquímicos para la valorización de productos y servicios bajo un modelo sostenible de economía circular.

Economía circular: química y bioquímica

Hosted by Youssuf Elshabrawy, CoHosted by Jason Simo, Guest Speaker: Ariq Wahid